Remed Co.,Ltd. (KOSDAQ:302550)

Market Cap	93.49B
Revenue (ttm)	24.26B
Net Income (ttm)	3.28B
Shares Out	30.91M
EPS (ttm)	103.55
PE Ratio	29.21
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,526
Average Volume	72,841
Open	3,065.00
Previous Close	3,025.00
Day's Range	3,015.00 - 3,065.00
52-Week Range	2,965.00 - 4,595.00
Beta	0.79
RSI	37.84
Earnings Date	Nov 11, 2025

About Remed

Remed Co.,Ltd. engages in the manufactures and supplies of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as tinnitus, insomnia, dementia, stress, anxiety, etc. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In addition, the company provides e...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2003
• Employees: 92
• Stock Exchange: KOSDAQ
• Ticker Symbol: 302550

Financial Performance

In 2024, Remed's revenue was 25.55 billion, an increase of 37.86% compared to the previous year's 18.54 billion. Earnings were 7.17 billion, an increase of 799.69%.